vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Dime Community Bancshares, Inc. (DCOM). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $123.8M, roughly 1.5× Dime Community Bancshares, Inc.). On growth, Dime Community Bancshares, Inc. posted the faster year-over-year revenue change (3040.1% vs 0.7%). Over the past eight quarters, Dime Community Bancshares, Inc.'s revenue compounded faster (22.9% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
The Dime Community Bank, originally known as the Dime Savings Bank of Williamsburgh, is a local, FDIC-insured bank headquartered in Hauppauge, New York. Founded in 1864, the bank was originally based in the Williamsburg neighborhood of Brooklyn, New York, and continues to operate with a strong market presence in this area. In 2017, Dime moved its headquarters to Brooklyn Heights. On Monday, February 1, 2021, Bridge Bancorp Inc. and Dime Community Bancshares successfully closed on a merger of ...
AVNS vs DCOM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $123.8M |
| Net Profit | $-1.3M | — |
| Gross Margin | 47.5% | — |
| Operating Margin | 1.4% | 38.6% |
| Net Margin | -0.7% | — |
| Revenue YoY | 0.7% | 3040.1% |
| Net Profit YoY | 99.7% | — |
| EPS (diluted) | $-0.02 | $0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $123.8M | ||
| Q3 25 | $177.8M | $115.6M | ||
| Q2 25 | $175.0M | $109.7M | ||
| Q1 25 | $167.5M | $103.8M | ||
| Q4 24 | $179.6M | $3.9M | ||
| Q3 24 | $170.4M | $87.6M | ||
| Q2 24 | $171.7M | $87.3M | ||
| Q1 24 | $166.1M | $82.0M |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $-1.4M | $27.7M | ||
| Q2 25 | $-76.8M | $29.7M | ||
| Q1 25 | $6.6M | $21.5M | ||
| Q4 24 | $-397.3M | — | ||
| Q3 24 | $4.3M | $13.3M | ||
| Q2 24 | $1.8M | $18.5M | ||
| Q1 24 | $-900.0K | $17.7M |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | 38.6% | ||
| Q3 25 | 0.1% | 34.7% | ||
| Q2 25 | -42.6% | 36.6% | ||
| Q1 25 | 6.1% | 27.6% | ||
| Q4 24 | -233.0% | -433.6% | ||
| Q3 24 | 7.0% | 20.8% | ||
| Q2 24 | 3.7% | 29.8% | ||
| Q1 24 | 2.4% | 29.6% |
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.8% | 23.9% | ||
| Q2 25 | -43.9% | 27.1% | ||
| Q1 25 | 3.9% | 20.7% | ||
| Q4 24 | -221.2% | — | ||
| Q3 24 | 2.5% | 15.2% | ||
| Q2 24 | 1.0% | 21.2% | ||
| Q1 24 | -0.5% | 21.6% |
| Q4 25 | $-0.02 | $0.68 | ||
| Q3 25 | $-0.03 | $0.59 | ||
| Q2 25 | $-1.66 | $0.64 | ||
| Q1 25 | $0.14 | $0.45 | ||
| Q4 24 | $-8.64 | $-0.58 | ||
| Q3 24 | $0.09 | $0.29 | ||
| Q2 24 | $0.04 | $0.43 | ||
| Q1 24 | $-0.02 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | — |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $1.5B |
| Total Assets | $1.1B | $15.3B |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | — | ||
| Q3 25 | $70.5M | — | ||
| Q2 25 | $90.3M | — | ||
| Q1 25 | $97.0M | — | ||
| Q4 24 | $107.7M | — | ||
| Q3 24 | $89.0M | — | ||
| Q2 24 | $92.2M | — | ||
| Q1 24 | $75.8M | — |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $1.5B | ||
| Q3 25 | $778.0M | $1.5B | ||
| Q2 25 | $776.3M | $1.4B | ||
| Q1 25 | $839.4M | $1.4B | ||
| Q4 24 | $828.5M | $1.4B | ||
| Q3 24 | $1.2B | $1.3B | ||
| Q2 24 | $1.2B | $1.3B | ||
| Q1 24 | $1.2B | $1.2B |
| Q4 25 | $1.1B | $15.3B | ||
| Q3 25 | $1.1B | $14.5B | ||
| Q2 25 | $1.0B | $14.2B | ||
| Q1 25 | $1.1B | $14.1B | ||
| Q4 24 | $1.2B | $14.4B | ||
| Q3 24 | $1.7B | $13.7B | ||
| Q2 24 | $1.7B | $13.5B | ||
| Q1 24 | $1.7B | $13.5B |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $186.6M |
| Free Cash FlowOCF − Capex | $21.3M | — |
| FCF MarginFCF / Revenue | 11.8% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $186.6M | ||
| Q3 25 | $14.0M | $52.1M | ||
| Q2 25 | $6.8M | $23.1M | ||
| Q1 25 | $25.7M | $65.4M | ||
| Q4 24 | $57.9M | $99.1M | ||
| Q3 24 | $23.0M | $-33.3M | ||
| Q2 24 | $27.8M | $12.6M | ||
| Q1 24 | $-8.0M | $30.7M |
| Q4 25 | $21.3M | — | ||
| Q3 25 | $7.0M | $51.2M | ||
| Q2 25 | $-4.2M | $20.4M | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $53.1M | — | ||
| Q3 24 | $20.0M | $-34.1M | ||
| Q2 24 | $21.9M | $9.2M | ||
| Q1 24 | $-12.1M | — |
| Q4 25 | 11.8% | — | ||
| Q3 25 | 3.9% | 44.3% | ||
| Q2 25 | -2.4% | 18.6% | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 29.6% | — | ||
| Q3 24 | 11.7% | -38.9% | ||
| Q2 24 | 12.8% | 10.5% | ||
| Q1 24 | -7.3% | — |
| Q4 25 | 3.8% | — | ||
| Q3 25 | 3.9% | 0.7% | ||
| Q2 25 | 6.3% | 2.4% | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 1.8% | 0.9% | ||
| Q2 24 | 3.4% | 3.9% | ||
| Q1 24 | 2.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.88× | ||
| Q2 25 | — | 0.78× | ||
| Q1 25 | 3.89× | 3.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | -2.50× | ||
| Q2 24 | 15.44× | 0.68× | ||
| Q1 24 | — | 1.74× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
DCOM
Segment breakdown not available.
